Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by MedStocks2on Jan 25, 2020 10:15pm

64 Views

Post# 30599492

RE:RE:RE:RE:News Very Soon (I hope!)

If you read Midams web site you would know they need grist for the mill. Also they made it clear that they will be buying shares ahead of their pump. Co UK ld be they are the ones scavenging shares. As soon as the the next news is out you will surely see their pump ops in full swing. Then they will be dumping on the high.

Bullboard Posts

What will the U.S. election results mean for Canada?